Cormorant Pharmaceuticals
SwedenEntry
2012
Hold
4yr
Exit
2016
Who owns Cormorant Pharmaceuticals?
Cormorant Pharmaceuticals is a Swedish Biotech company, now owned by Bristol Myers Squibb, which acquired it in 2016 from Flerie.
Hand-verified · updated 2026-08-17
Open JSON · CC-BYExit Type
Trade Sale
Buyer
Bristol Myers Squibb
Exit Year
2016
More from Flerie Invest
Other portfolio companies in the same fund.
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Cormorant Pharmaceuticals?
Cormorant Pharmaceuticals is now owned by Bristol Myers Squibb, which acquired it in 2016 from Flerie.
When did Bristol Myers Squibb acquire Cormorant Pharmaceuticals?
Bristol Myers Squibb acquired Cormorant Pharmaceuticals in 2016, buying from Flerie.
Who did Cormorant Pharmaceuticals sell to?
Flerie sold Cormorant Pharmaceuticals to Bristol Myers Squibb in 2016 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue